The Effectiveness of a Brief Motivational Nursing Intervention (BMNI)

October 11, 2019 updated by: Isabel Almodóvar Fernández, Cardenal Herrera University

The Effectiveness of a Brief Motivational Nursing Intervention to Reduce Psychoactive Substance Consumption in Entertainment-sector Workers: A Transversal, Observation, and Semi-experimental Study

This was a two-staged study undertaken in entertainment-sector workers in Spain: the first part was transversal and observational, and the second was semi-experimental. A short group-based motivational intervention session was implemented by nursing staff, and a before and after evaluation was completed. By reducing the patients' perception of their quality of life, this brief nursing intervention facilitated a favourable increase in the motivation for change among these workers and was effective in 12% of cases.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Checking whether changes in the perception of the quality of life related to health, after the nursing intervention, influence these patients' motivation to change. This was a two-staged study undertaken in entertainment-sector workers in Spain: the first part was transversal and observational, and the second was semi-experimental. First part undertook in 284 entertainmentsector workers, selected by non-probabilistic sampling, while second part undertook in 50 entertainment-business workers, selected by consecutive sampling from those who consumed substances. A short group-based motivational intervention session was implemented by nursing staff, and a before and after evaluation was completed. The EuroQol-5D and Test for the Evaluation of the Quality of Life in Addicts to Psychoactive Substances (TECVASP) were used. The patients' motivation to change was evaluated through the Stages of Change Readiness and Treatment Eagerness Scale.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
    • Castellón
      • Castellón De La Plana, Castellón, Spain, 12006
        • University CEU Cardenal Herrera

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age between 18 and 65 years
  • working conditions that fulfilled the Health and Safety requirements
  • acceptance of the informed consent to participation.
  • Drugs and alcohol users

Exclusion Criteria:

  • younger than 18 or older than 65
  • Non drugs and alcohol users

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group
Based on NANDA diagnosis recommendations, entertainment-sector workers were asked to record their perceptions and the meaning of their substance-use problem in a diary. The intervention was subsequently designed based on brief motivational psychoeducational therapy (BMPT).
Behavioral: brief motivational psychoeducational therapy
The brief motivational psychoeducational therapy (BMPT) it lasted an average of 90 min and followed the following structure: (i) brainstorming the concepts of health, lifestyle, and substance-use prevention; (ii) analysis of a work accident at an international rock group concert, which was used to generate (iii), a debate on consumer habits (30 min); (iv) discussion of the substance types and classifications known by the participants; (v) Prochaska and DiClemente's stages of change and (vi), the consequences of drug use (50 min); and finally, (vii) a true/false quiz used to discuss myths and beliefs about drugs (10 min).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
General perception of health related quality of life EQ-5D-3L
Time Frame: At 1 month
Health related quality of life (HRQL) meassured by EQ-5D (EuroQuol) The EQ-5D-3L descriptive system comprises the following 5 dimensions, each describing a different aspect of health: mobility, self-care, usual activities, pain/disconfort and anxiety/depression. Each dimension has 3 respnse levels of severity: no problems, some problems, extreme problems. The respondent is asked to indicate his/her health state by checking the box next to the most appropiate response level of each five dimensions.
At 1 month
Health related quality of life TECVASP
Time Frame: At 1 month

Assessment of the Quality of Life in Psychoactive Substance Addicts Test TECVAS

It consists of 22 items (18 positive and 4 negative [items 15, 19, 20 and 21]) with a graded response format of five alternatives. The response alternatives are coded with the following alternatives: a) in the positive items: nothing (5 points), little (4 points), sometimes (3 points), enough (2 points) and much (1 point); b) in the negative items: nothing (1 point), little (2 points), sometimes (3 points), enough (4 points) and much (5 points). Therefore, in each element, a higher score represents a more positive evaluation of the content, and in the test, a higher score represents a better HRQL.
At 1 month
Motivation to change
Time Frame: At 1 month
Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES Scale) SOCRATES is an experimental instrument designed to assess readiness for change in alcohol and drugs abusers. The instrument yields three factorially-derived scale scores: Recognition (Re), Ambivalence (Am), and Taking Steps (Ts). It is a public domain instrument and may be used without special permission. The statements describes a way that the user might (or might not) feel about his/her drug use. For each statement, he/she has to circle one number from 1 to 5, to indicate how much they agree or disagree with it right now.
At 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cardenal Herrera University

Investigators

  • Study Director: Gonzalo Haro Cortés, Dr, Universidad CEU cardenal Herrera-Consorcio Hospitalario Provincial de Castellón

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2016

Primary Completion (Actual)

October 31, 2016

Study Completion (Actual)

October 31, 2016

Study Registration Dates

First Submitted

September 30, 2019

First Submitted That Met QC Criteria

October 11, 2019

First Posted (Actual)

October 14, 2019

Study Record Updates

Last Update Posted (Actual)

October 14, 2019

Last Update Submitted That Met QC Criteria

October 11, 2019

Last Verified

October 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • DGNRI316-06-23

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Behavior, Addictive

Clinical Trials on brief motivational psychoeducational therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe